MAPT and Alzheimer disease: Authors found specific antibodies to both p-tau and tau in most subjects, regardless of cognitive status, with increased specific IgG binding to p-tau (an increase in the p-tau IgG ratio) detected in MCI subjects as compared to AD patients and healthy controls 80.